Plain-English translation of NCT07062497 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether adding clonidine—a medication that may help control pain—to numbing injections used during hernia surgery improves pain relief and recovery. You would receive ultrasound-guided numbing injections to block pain in the area around your hernia repair, with half of participants getting the medication added and half receiving the numbing injection alone. The study aims to see if the medication makes surgery more comfortable, reduces the amount of opioid painkillers you need, and helps you recover better after your outpatient procedure.
Currently, doctors use numbing injections to control pain during hernia repairs, but some patients still experience significant pain or need strong opioid medications afterward. This trial is exploring whether adding this medication to the numbing injection could provide better pain relief and help patients recover faster without needing as many opioids.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the numbing injection alone or the numbing injection with the added medication. Before surgery, medical staff will place ultrasound-guided numbing injections around your surgical area. You will then have your hernia repair performed as an outpatient procedure. After surgery, you will be monitored in the recovery area and asked about your pain levels and how you are feeling. You will also complete questionnaires about your pain and recovery quality at 24 and 48 hours after surgery.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
Brazil